Josephine Fubara is a an award-winning R&D executive and respected leader with over 20 years of experience in the pharmaceutical industry. A subject matter expert in strategic partnerships, product development, third party development, technology transfer, commercialization, and alliance governance models, Josephine is known for her proactive way of working, often lending foresight which allows her to address challenges before they even arise. Focused on building a high-performing, engaged team, Josephine prioritizes people, confident that relationships are what increase value and drive growth across teams and organizations.
Currently, she is the Global Head of Therapeutics, R&D at Bayer. She and her team are responsible for developing and executing new innovations for pain, cardio, allergy, cough/cold, and digestive health which collectively is worth €2.8 billion of business. Always innovative and cross-functional, Josephine takes pride in leading a team that is committed to creating the ultimate consumer experience.
Born in Nigeria, Josephine obtained a Pharmacy degree from the University of Benin, Nigeria and a Ph.D. in Pharmaceutics from the Medical University of South Carolina. Prior to her time at Bayer, Josephine was in various technical and business roles with Whitehall Robins, Wyeth, and Pfizer. In 2014, she was honored with the Healthcare Business Women’s Association Award recognizing the successful launch of a pioneer initiative and for advancing Pfizer’s commitment to the development of future women leaders.
A loyal champion of women, Josephine is a long-standing member of Advancing Women Executives an organization with the mission to create equity and economic growth at work. She is focused on passing her knowledge to help and empower the next generation of women leaders.
When she is not in the office, Josephine can be found hiking, reading, traveling, watching a movie, or catching up with her two adult children. She and her husband, Mike, call New Jersey their home.